Drug Studies Should Be Powered For Safety As Well As Efficacy, FDAer Says
Executive Summary
Drug studies should be powered to assess safety rather than efficacy alone, FDA Office of Pharmacoepidemiology & Statistical Sciences Associate Director for Science, John Senior, MD said at the Pharmaceutical Education Associates Pharmaceutical Risk Management Workshop in Philadelphia Dec. 9